Hot Features
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive ... Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.19 | 18.8291139241 | 6.32 | 7.51 | 6.28 | 710692 | 6.84235639 | CS |
| 4 | -0.17 | -2.21354166667 | 7.68 | 7.78 | 5.85 | 732231 | 6.50393924 | CS |
| 12 | -2.16 | -22.3371251293 | 9.67 | 10.6676 | 5.85 | 616471 | 8.10407271 | CS |
| 26 | -19.79 | -72.4908424908 | 27.3 | 33.68 | 5.85 | 928881 | 12.08622643 | CS |
| 52 | -3.28 | -30.3985171455 | 10.79 | 33.68 | 5.85 | 695915 | 15.00125404 | CS |
| 156 | -13.99 | -65.0697674419 | 21.5 | 33.68 | 5.14 | 547987 | 14.59684509 | CS |
| 260 | -13.99 | -65.0697674419 | 21.5 | 33.68 | 5.14 | 547987 | 14.59684509 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.